111 related articles for article (PubMed ID: 35786686)
1. A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro.
Cen W; Reinert S; Avci-Adali M; Alexander D; Umrath F
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786686
[TBL] [Abstract][Full Text] [Related]
2. Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis.
Koek WNH; van der Eerden BCJ; Alves RDAM; van Driel M; Schreuders-Koedam M; Zillikens MC; van Leeuwen JPTM
Bone; 2017 Feb; 95():108-114. PubMed ID: 27845263
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.
Miyazaki T; Miyauchi S; Anada T; Imaizumi H; Suzuki O
Anal Biochem; 2011 Mar; 410(1):7-12. PubMed ID: 21078287
[TBL] [Abstract][Full Text] [Related]
4. Osteoclasts on bone and dentin in vitro: mechanism of trail formation and comparison of resorption behavior.
Rumpler M; Würger T; Roschger P; Zwettler E; Sturmlechner I; Altmann P; Fratzl P; Rogers MJ; Klaushofer K
Calcif Tissue Int; 2013 Dec; 93(6):526-39. PubMed ID: 24022329
[TBL] [Abstract][Full Text] [Related]
5. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
Van Beek ER; Löwik CW; Papapoulos SE
Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
[TBL] [Abstract][Full Text] [Related]
7. S 12911-2 inhibits osteoclastic bone resorption in vitro.
Takahashi N; Sasaki T; Tsouderos Y; Suda T
J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
[TBL] [Abstract][Full Text] [Related]
8. Aminothiazoles inhibit osteoclastogenesis and PGE
Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
[TBL] [Abstract][Full Text] [Related]
9. PPAR agonists modulate human osteoclast formation and activity in vitro.
Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA
Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686
[TBL] [Abstract][Full Text] [Related]
10. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
11. Novel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts.
Petrova NL; Petrov PK; Edmonds ME; Shanahan CM
Calcif Tissue Int; 2014 Apr; 94(4):403-11. PubMed ID: 24322885
[TBL] [Abstract][Full Text] [Related]
12. Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis.
Liu Z; Liang W; Kang D; Chen Q; Ouyang Z; Yan H; Huang B; Jin D; Chen Y; Li Q
Clin Interv Aging; 2020; 15():1201-1212. PubMed ID: 32764906
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast formation from circulating precursors in osteoporosis.
Jevon M; Hirayama T; Brown MA; Wass JA; Sabokbar A; Ostelere S; Athenasou NA
Scand J Rheumatol; 2003; 32(2):95-100. PubMed ID: 12737328
[TBL] [Abstract][Full Text] [Related]
14. Effects of ethanol on bone cells in vitro resulting in increased resorption.
Cheung RC; Gray C; Boyde A; Jones SJ
Bone; 1995 Jan; 16(1):143-7. PubMed ID: 7742073
[TBL] [Abstract][Full Text] [Related]
15. Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
Sun P; Yang Q; Wang Y; Peng J; Zhao K; Jia Y; Zhang T; Lu X; Han W; Qian Y
Drug Des Devel Ther; 2020; 14():4189-4203. PubMed ID: 33116407
[TBL] [Abstract][Full Text] [Related]
16. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J
Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577
[TBL] [Abstract][Full Text] [Related]
17. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
[TBL] [Abstract][Full Text] [Related]
18. Optimized transfection of diced siRNA into mature primary human osteoclasts: inhibition of cathepsin K mediated bone resorption by siRNA.
Selinger CI; Day CJ; Morrison NA
J Cell Biochem; 2005 Dec; 96(5):996-1002. PubMed ID: 16149069
[TBL] [Abstract][Full Text] [Related]
19. Volumetric analysis of osteoclastic bioresorption of calcium phosphate ceramics with different solubilities.
Winkler T; Hoenig E; Gildenhaar R; Berger G; Fritsch D; Janssen R; Morlock MM; Schilling AF
Acta Biomater; 2010 Oct; 6(10):4127-35. PubMed ID: 20451677
[TBL] [Abstract][Full Text] [Related]
20. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
Lees RL; Heersche JN
J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
